Skip to main content

Influenza

Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults
NCT04576702 | PHASE 2 | INTERVENTIONAL

This Phase 2, randomized, observer-blind, active controlled clinical study is evaluating the safety and immunogenicity of the investigational MF59-Adjuvanted Quadrivalent Subunit Inactivated Influenza Vaccine. Approximately 480 subjects are to be randomized into 1 of 4 possible treatment groups (investigational Influenza Vaccine or licensed Quadrivalent Influenza Vaccine comparators) at 120 participants per group. Every participant will receive an influenza vaccine injection on Day 1 and will be followed up for approximately 6 months following injection. The primary immunogenicity analysis is based on Day 29 serum.

Trial Information
21 Sites
471 Participants
Recruiting
50 Years to 64 Years

If interested, contact clinicaltrials@cslbehring.com for more information

CSL Behring respects your privacy. For an explanation of how CSL Behring will use the information you are submitting, please view our Privacy Policy

Coastal Clinical Research, an AMR company
Mobile,Alabama,United States,36608
Clinical Research Consortium, an AMR company
Tempe,Arizona,United States,85283
Westside Center for Clinical Research
Jacksonville,Florida,United States,32205
Jacksonville Center for Clinical Research
Jacksonville,Florida,United States,32216
Research Centers of America, LLC
Oakland,Florida,United States,33334
Advanced Clinical Research
Boise,Idaho,United States,83642
Heartland Research Associates, LLC
Newton,Kansas,United States,67114
Heartland Research Associates, LLC An AMR Company
Wichita,Kansas,United States,67207
Central Kentucky Research Associates, an AMR company
Lexington,Kentucky,United States,40509
Medpharmi
Kenner,Louisiana,United States,70065
The Center for Pharmaceutical Research, an AMR company
Kansas City,Missouri,United States,64114
Sundance Clinical Research, LLC
Saint Louis,Missouri,United States,63141
Meridian Clinical Research, LLC
Omaha,Nebraska,United States,68134
Regional Clinical Research United Medical Associates
Binghamton,New York,United States,13901
M Wake Research, Inc.
Raleigh,North Carolina,United States,27612
Sterling research
Cincinnati,Ohio,United States,45219
Rapid Medical Research, Inc.
Cleveland,Ohio,United States,44122
Lynn Health Science Institute
Oklahoma City,Oklahoma,United States,73112
Clinical Trials of Texas, Inc.
San Antonio,Texas,United States,78229
Martin Diagnostic Clinic
Tomball,Texas,United States,77375
Advanced Clinical Research
West Jordan,Utah,United States,84088

Study Eligibility Criteria

Additional Studies

Additional studies can be found at ClinicalTrials.gov